Science

Buddy Moon: Lisa & Tom (City of Grove)” by Rhonda Boehm Takes Readers on a Journey of Love,Redemption,and Self-Discovery

🕔11/12/2024 3:16:06 PM

In “Buddy Moon: Lisa & Tom (City of Grove)”, author Rhonda Boehm delivers an engaging romance set against the idyllic backdrop of Hawaii. The story follows two people from vastly different worlds, each on their journey of healing and self-acceptance, as they attempt to open their hearts to love while grappling with their pasts.

Read Full Article

Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults

🕔11/12/2024 12:44:01 AM

GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.

Read Full Article

Breakthrough – An Integrated Air and Ground C5ISR CJADC2 System

🕔11/11/2024 9:46:28 PM

AGIS' C5ISR combined Air and Ground C5ISR System fulfills the need for an integrated, All-Domain, C5ISR combined arms capability that can seamlessly operate either as an independent Air and Ground system or can function as an integrated Air and Ground C5ISR System capable of simultaneously performing both Air and Ground functions.

Read Full Article

Multimodal Protocol for Anticoagulation Monitoring in ECMO Patients: Safety Analysis of Anti-Xa and VCM Monitoring

🕔11/11/2024 6:36:47 PM

Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.

Read Full Article

Neurizon Therapeutics Teams Up with GenieUs Genomics to Leverage Cutting-Edge Genomic Profiling in NUZ-001 Phase 1 Trial

🕔11/7/2024 1:00:00 PM

GenieUs Genomics (“GenieUs”) is excited to provide advanced genomic analysis for Neurizon Therapeutics Limited’s (“Neurizon”; ASX:NUZ; ASX:NUZOA) Phase 1 clinical trial of monepantel, now known as NUZ-001, marking an important step in understanding the genetic landscape of ALS patients.

Read Full Article

"From Fear to Peace" by Alexia Franklin Offers a Unique Path to Overcoming Life's Challenges

🕔11/5/2024 1:57:59 PM

“From Fear to Peace” is more than just a self-help guide; it’s a practical toolkit designed to help readers navigate life’s toughest challenges with clarity and calm.

Read Full Article

MOIN Successfully Complete POC for Cross-Border Tuition Payments, Paving the Way for Solution Commercialization

🕔11/5/2024 1:55:43 AM

MOIN, a leading cross-border remittance service provider, has successfully collaborated with Visa to address a long-standing challenge in cross-border payments: the inability to seamlessly transmit detailed non-financial data alongside financial transactions.

Read Full Article